Prognostic and predictive impact of genetic markers in patients with CLL treated with obinutuzumab and venetoclax.
Blood. 2020 Jun 25;135(26):2402-2412. doi: 10.1182/blood.2019004492.
Blood. 2020.
PMID: 32206772
Free article.